Astrazeneca

FromAstraZeneca ([email protected])
Subject (76)Fasenra approved in the US for eosinophilic granulomatosis with polyangiitis
Preheader (76)Fasenra approved in the US for eosinophilic granulomatosis with polyangiitis
Typography
Arial
Colors
Text Analysis
Body Words180
Subject Words10
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images7
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px690 px
X-Spam Score-0.1
Preheader OptimizedNo
Timing
Day of WeekThursday
TimeMorning

Fasenra approved in the US for eosinophilic granulomatosis with polyangiitis

Fasenra approved in the US for eosinophilic granulomatosis with polyangiitis
Fasenra approved in the US for eosinophilic granulomatosis with polyangiitis